Table 1 Indications for cement augmentation
(1) Absolute indications for cement augmentation of a vertebral body or bodies due to fracture: |
• Persistent significant pain from a fractured vertebral body confirmed on MRI scanning with STIR images. This fracture could be acute, sub-acute or chronic (often has a fracture cleft) and has not healed |
• Persistent significant symptoms which have not resolved with normal conservative measures after 4 weeks of treatment affecting daily activities |
• Significant pain due to a fractured vertebral body affecting activity |
• Significant pain associated with significant change in disability in conjunction with a new event |
• Acute patient-delayed for medical reasons |
• Selective chronic fractures |
• Complications for myeloma should be treated first and pain is not defined by a specific VAS number |
• Timing is important, especially newly diagnosed patients. Immediate referral for treatment for very severe pain requiring high dose of analgesics |
(2) Relative indications for cement augmentation of a vertebral body or bodies due to fracture: |
• Fracture of the thoracolumbar junction (T10–L2) that could result in a significant kyphotic deformity and therefore morbidity |
• Loss of vertebral body height (progressive as evidenced by sequential erect x-rays) |
• Posterior wall defect or destruction of a pedicle/pars which may potentially render the affected area of the spine unstable and at risk of fracture/neurological insult new tumour classification system to delineate vertebral bodies at risk of impending fracture as a result of metastatic spinal disease82,83. May be used for classification for myeloma patients as well but this needs to be myeloma spinal disease validated |
(3) Conditional or prophylactic indications for cement augmentation of a vertebral body or bodies due to fracture: |
(A) Loss of vertebral height sufficient to affect functional activities |
• Fracture at T10–L2 (thoraco-lumbar junction) consider cement augmentation; below L2 is not as significant |
• Only if progression over time; follow up with standard x-rays every 1–3 months |
(B) Risk of impending fracture |
• Need to take into consideration the aggressive nature of the disease and patient activity |
• “Impending fractures” hard to determine |
• Need for clinical trials |